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The value of the exercise-electrocardiography test in detect-
ing coronary artery disease in women is limited. Recently, 
the high dose dipyridamole-echocardiography test (two-
dimensional echocardiographic monitoring during intrave-
nous dipyridamole infusion, up to 0.84 mg/kg body weight 
over 10 min) was proposed as an alternative to exercise 
testing for the diagnosis of coronary artery disease. To 
establish the diagnostic usefulness of the exercise-
electrocardiography and dipyridamole-echocardiography 
tests in this disease, the two tests were performed~n 
different days and in random order-in 83 consecutive 
women evaluated for a chest pain syndrome. All 83 women 
had taken no medications for >48 h, and 15 had had a 
previous myocardial infarction. 
Positivity of the dipyridamole-echocardiography test 
was based on detection of a transient asynergy of contrac-
tion that was absent or of lesser degree at rest; the 
exercise-electrocardiography test (by upright cycloergo-
meter) was considered positive when the ST segment was 
The noninvasive diagnosis of coronary artery disease in 
women with a chest pain syndrome remains a difficult 
clinical problem, In fact, the most frequently used tool to 
detect coronary artery disease, that is, the exercise-
electrocardiography test, has not proved reliable in women 
(1-6). Other diagnostic noninvasive methods to detect coro-
nary artery disease are therefore needed; exercise thallium-
201 scintigraphy (7-9) and radionuclide ventriculography 
(10) have been proposed for this purpose. 
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shifted >0.1 mV 0.08 s after the J point. Coronary angi-
ography showed significant coronary artery disease (>70% 
luminal reduction of at least one major coronary vessel) in 
39 women. No significant complications occurred in any 
patient during either test. 
Sensitivity and predictive value of a negative test were 
similar for the dipyridamole-echocardiography and the 
exercise-electrocardiography test (79 versus 72 % and 84 
versus 68%, respectively, whereas the dipyridamole-
echocardiography test had greater specificity (93 versus 
52%, p < 0.001), accuracy (87 versus 62%, p < 0.001) and 
a higher predictive value of a positive test (91 versus 57%, 
p < 0.01). 
Thus, the dipyridamole-echocardiography test appears 
to be of greater diagnostic value than does the exercise-
electrocardiography test for noninvasive detection of coro-
nary artery disease in women. 
(J Am Coil CardioI1988;12:682-S) 
In our laboratory we recently demonstrated (11-14) that 
the dipyridamole-echocardiography test-that is, two-
dimensional echocardiographic monitoring during dipyrida-
mole infusion, up to 0.84 mg/kg body weight over 10 min-
can be a useful exercise-independent tool in evaluating 
patients with suspected coronary artery disease. These 
previous studies were performed in study groups with a large 
predominance of men. The aim of the present study was to 
determine whether the dipyridamole-echocardiography test 
may represent a reliable alternative to the exercise-
electrocardiography test in detecting coronary artery disease 
in women. 
Methods 
Selection of patients. Eighty-three consecutive women 
who were referred to our institute for evaluation of chest 
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pain were studied. Their mean age was 55 ± 8 years (range 
38 to 69). A baseline echocardiogram of acceptable quality 
and ability to exercise adequately were inclusion criteria. 
Fifteen women had had a previous myocardial infarction; 
women with valvular heart disease, conduction distur-
bances, cardiac failure, unstable angina or cardiomyopathy 
were not included. Two more women had excessive tachy-
cardia after the first dipyridamole infusion (see later); they 
were not given the second dose and therefore were not 
included in the study. 
All women performed, on different days and in random 
order, a dipyridamole-echocardiography test and an exer-
cise-electrocardiography test and underwent coronary angi-
ography. All medications (cardiologic and noncardiologic) 
were stopped for 2:48 h before each test. The dipyridamole-
echocardiography test was also performed by a control 
group of 10 asymptomatic young women (aged 20 to 30 
years). 
Exercise-electrocardiography test. Patients performed a 
multistage bicycle ergometer test in the upright position with 
an initial load of 25 Wand subsequent increments of 25 W/2 
min. A 12 lead electrocardiogram (ECG) and systolic and 
diastolic blood pressure were recorded basally and each 
minute. End points of the test were moderately severe chest 
pain, >0.2 m V ST segment shift, limiting dyspnea or fatigue. 
ECG tracings were considered diagnostic for myocardial 
ischemia when an ST segment shift >0.10 mV 0.08 s after the 
J point occurred. 
Dipyridamole-echocardiography test. Two-dimensional 
echocardiographic and 12 lead ECG monitoring were per-
formed in combination with a dipyridamole infusion (12) of 
0.56 mg/kg over 4 min followed by 4 min of no dose and then 
0.28 mg/kg in 2 min. The cumulative dose was therefore 0.84 
mg/kg over 10 min. 
Intravenous aminophylline (240 mg), which promptly 
reverses the effects of dipyridamole, was readily at hand. 
During the procedure, the blood pressure and ECG were 
recorded each minute. ECG criteria for ischemia during this 
test were the same as during the exercise-electrocardio-
graphy test. 
Two-dimensional echocardiograms were continuously re-
corded during and up to 20 min after dipyridamole adminis-
tration with the patient lying in the left lateral position. All 
standard echocardiographic views (mainly parasternal and 
apical) were obtained when possible. The videotapes were 
analyzed by two independent observers who were unaware 
of other data. In case of disagreement, a third observer 
reviewed the study and his judgment was binding. Segmental 
anatomy and wall motion were assessed as previously re-
ported (12). 
Positivity of the test was linked to the detection of a 
transient asynergy of contraction that was absent or of lesser 
degree in the baseline examination. Any region already 
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akinetic or dyskinetic in the baseline study was not consid-
ered for analysis. 
Angiographic study. Patients underwent biplane left ven-
triculography and selective right and left coronary arteriog-
raphy using either the Judkins or the Sones technique. 
Multiple views of each coronary artery were obtained, 
including craniocaudal views. Two independent observers 
analyzed coronary angiograms. A vessel was considered to 
have significant obstruction if its diameter was narrowed by 
2:70% (50% for the left main coronary artery) with respect to 
the prestenotic segment. 
Statistical analysis. The chi-square test was employed 
and a p value <0.05 was considered statistically significant. 
For both the dipyridamole-echocardiography test and the 
exercise-electrocardiography test, sensitivity, specificity, 
accuracy and predictive value of a positive and negative test 
in detecting angiographically assessed coronary artery dis-
ease were calculated according to standard definitions (15). 
Results 
Coronary arteriographic findings. Coronary angiography 
demonstrated absence or only nonsignificant coronary artery 
disease in 44 of the 83 women and significant coronary artery 
disease in 39. Of these 39, 15 had one vessel, 16 had two 
vessel and 6 had three vessel disease; left main coronary 
artery disease was found in two women. Thirteen of the 15 
women with previous myocardial infarction had significant 
coronary artery disease (the remaining 2 women had <70% 
single vessel disease). The prevalence of coronary artery 
disease (calculated as the number of patients with coronary 
artery disease per number of patients in the study group x 
100) was 47%; however, if women with previous myocardial 
infarction are excluded, the prevalence of coronary artery 
disease is lowered to 38%. 
Dipyridamole-echocardiography test. Two-dimensional 
echocardiographic studies were adequate for analysis and 
unchanged quality compared with the baseline examination 
in all 83 women. Of the 39 women with coronary artery 
disease, 31 (79%) had a positive dipyridamole-echocardiog-
raphy test, with the development of transient ventricular 
asynergy; 3 (7%) of the 44 women without coronary artery 
disease also had a positive dipyridamole-echocardiography 
test. Diagnostic ECG changes and chest pain were present 
during the dipyridamole-echocardiography test in 24 (62%) 
and 30 (77%) women with coronary artery disease, and in 22 
(50%) and 24 (55%) women without coronary artery disease, 
respectively (Fig. 1). 
During the dipyridamole-echocardiography test, no 
women had significant complications, that is, substained 
arrhythmias, severe hypotension or myocardial infarction. 
Extracardiac side effects (headache, nausea, flushing, dysp-
nea) occurred in 61 women (73%); these effects were not 
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Figure 1. Occurrence of ischemic echocardiographic (ECHO) 
changes, electrocardiographic (ECG) changes and angina (PAIN) 
during the dipyridamole-echocardiography test in the 44 women 
without coronary artery disease (open bars) and in the 39 women 
with significant coronary atherosclerosis ( hatched bars). 
severe and therefore the test was completed in all. Intrave-
nous aminophylline was given in 58 women. 
All the 10 control subjects had a negative dipyridamole-
echocardiography test. None had diagnostic ECG changes 
during the test; three complained of mild chest pain. 
Exercise electrocardiography test. Of the 39 women with 
coronary artery disease, 28 (72%) had diagnostic ST segment 
shift during the test; 21 (48%) of the 44 women without 
coronary artery disease had a positive test as well. None of 
the 11 women with a negative exercise electrocardiography 
test and evidence of coronary artery disease had other signs 
suggestive of ischemia, such as complex ventricular ectopic 
activity or hypotension during the exercise-electrocardio-
graphy test. Four women did not attain 2::80% of their 
age-predicted heart rate. 
Twenty-three (59%) women with coronary artery disease 
and 15 (34%) without coronary artery disease complained of 
mild to moderate chest pain. No significant complications 
occurred in any woman during the exercise-electrocardio-
graphy test. 
Correlation with angiographic findings. With respect to 
angiographically assessed coronary artery disease, the dipy-
ridamole-echocardiography test and the exercise electrocar-
diography test demonstrated a similar sensitivity (79 versus 
72%, p = ns) and predictive value of a negative test (84 
versus 68%, p = ns). In contrast, the dipyridamole-
echocardiography test showed, with respect to the exercise 
electrocardiography test, significantly higher values of spec-
ificity (93 versus 52%, p < 0.001), accuracy (87 versus 62%, 
p < 0.001) and predictive value of a positive test (91 versus 
57%, p < 0.01). 
No significant differences in the analyzed variables were 
detected when the 68 women without previous myocardial 
infarction were compared with the entire group of 83 women 
(Fig. 2). Of the 13 women with coronary artery disease and 
previous myocardial infarction, 11 (85%) had a positive 
dipyridamole-echocardiography test and 10 (77%) had a 
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Figure 2. Graphic display of the analyzed variables for the exercise 
electrocardiography test (solid bars) and dipyridamole-echocardiog-
raphy test (open bars) in the restricted group of 68 women without 
previous myocardial infarction. Predict. + = predictive value of a 
positive test; Predict. - = predictive value of a negative test; *p < 
0.01; ** p < 0.001. 
Discussion 
Clinical implications. Our data show that the dipyrida-
mole-echocardiography test overcomes the major limitation 
of the exercise electrocardiography test in women: the lack 
of specificity, accuracy and predictive value of a positive 
test; in contrast sensitivity and the predictive value of a 
negative test were similar in these two tests. 
A separate analysis was performed in the 68 women who 
had not had a previous myocardial infarction (Fig. 2). The 
rationale for this analysis is that, in patients with previous 
myocardial infarction, the diagnosis of coronary artery dis-
ease is almost certain (even if the possibility of myocardial 
infarction with normal or minimally diseased coronary arter-
ies is well known-as was the case in 2 of our 15 women with 
previous infarction. Also in this subgroup without previous 
infarction, obviously characterized by a lower prevalence of 
coronary artery disease, a significant difference between the 
dipyridamole-echocardiography and exercise electrocardio-
graphy tests was recorded in terms of specificity, accuracy 
and predictive value of a positive test. 
Three patients in our study had false positive echocardio-
graphic results during the dipyridamole-echo cardiography 
test. Possible explanations for these results include human 
error (overdiagnosis), coronary vasospasm (not prevented 
by dipyridamole, which results in only a modest dilation in 
large vessels) or an early cardiomyopathy. 
Pathophysiologic implications. Why the exercise-
electrocardiography test has poor diagnostic utility in 
women is unknown. Some postulated explanations, such as 
the influence of psychoactive drugs (l5), are not consistent 
with our findings because our patients were studied without 
therapy. 
Positive ECG responses to both forms of stress were 
equally prevalent among women without significant coro-
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nary obstructions (Fig. 1), although in individual subjects an 
abnormal ECG response was sometimes induced by one test 
but not the other. 
Among the 49 women with a positive exercise-electrocar-
diography test, 2 had only moderate coronary stenosis (50 to 
70%); it therefore seems unlikely that this degree of narrow-
ing, although below the conventional value for angiographic 
diagnosis of coronary artery disease, would represent a 
mechanism of abnormal response to exercise (due to inability 
of angiography to accurately predict the physiologic impor-
tance of a stenosis) at least in the majority of women. 
The prevalence rate of coronary artery disease in our 
study was 47%, the highest rate among the previously 
mentioned studies (1-6). Even if women with previous 
myocardial infarction are excluded, our prevalence rate is 
still 38%. This high rate might be explained by the fact that 
our institute is a tertiary care referral center. Despite the 
greater prevalence of coronary artery disease in our study, 
the incidence of false positive responses during the exercise-
electrocardiography test is similar to that of the other studies 
(1-6). This is of interest because, according to Bayes' 
theorem, one would expect a reduction in false positive 
responses with the increase in pre-test probability of the 
disease (prevalence). 
Comparison with other studies. Echocardiographic re-
sults during the dipyridamole-echocardiography test do not 
seem to be affected by the gender of the study population 
because data obtained in this study are overlapped with 
those obtained in our previous study (12) performed on a 
population composed mostly of men. False-positive ECG 
results during the dipyridamole-echocardiography test were 
more frequent in the women of this study with respect to the 
previously mentioned group (12). 
It was recently stated (16) that "the value of the exercise-
electrocardiography test in the detection of coronary athero-
sclerotic heart disease in women is poor at best." Alterna-
tive tests have been proposed. Exercise thallium-201 
scanning proved to be the most reliable test, with a sensitiv-
ity range from 70 to 75% and a specificity range from 91 to 
97% (7-9). These values are similar to the sensitivity of 79% 
and specificity of 93% that we found for the dipyridamole-
echocardiography test in our study. In contrast, poor values 
for sensitivity and specificity were detected by Jones et al. 
(10) employing exercise radionuclide ventriculography. 
Limitations to the widespread use of thallium-201 scintig-
raphy, however, include the need for nuclear medicine 
facilities, which are not available in all centers; also, the 
required exposure of the patient to radiation and the consid-
erable cost of each test must be taken into account. This has 
led Melin et al. (9) to state that" ... it is not feasible, from 
a cost and risk point of view, to obtain a stress thallium 
scintigram from every woman complaining of chest pain," 
and thus to suggest its use only in selected subgroups of 
patients. The dipyridamole-echocardiography test has no ra-
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diation hazards and, from the viewpoint of feasibility, ease of 
performance, safety and cost, it is comparable with a "first 
line" test such as the exercise-electrocardiography test. 
Conclusions. The dipyridamole-echocardiography test 
might be proposed as the test of choice, more reliable than 
the exercise-electrocardiography test, for the noninvasive 
diagnosis of coronary artery disease in women. 
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